Skip to content

Validation of DNA Methylation Biomarkers for Oral Cancer Detection

Validation of DNA Methylation Biomarkers for Oral Cancer Detection

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01945697
Enrollment
267
Registered
2013-09-18
Start date
2012-12-31
Completion date
2014-09-30
Last updated
2017-12-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Cancer

Keywords

DNA methylation, biomarkers, oral cancer

Brief summary

The aim of this study is to evaluate the association between several methylated genes and oral cancers. A prospective case control trial is designed with sample size estimated at least 160 cases. It is expected to enroll at least 100 subjects with precancerous lesion or oral cancer, and \ 60 subjects with normal oral mucosa. This study is approved by the National Taiwan University Hospital Research Ethics Committee. After signing the informed consent, all of the subjects will receive an intraoral examination and the oral epithelial cells will be collected. If abnormal oral lesion is observed, it will be photographed, and the biopsy will be performed to confirm the diagnosis. For methylated gene detections, the gDNA will be extracted from the collected cells and standardized assay will be performed. Clinical sensitivity and specificity for these methylated genes will be evaluated.

Interventions

None listed

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subject with age over 20. * Subject agrees to sign the informed consent form.

Exclusion criteria

* Subjects have history of head and neck cancer. * Subjects have had received chemotherapy for cancers. * Pregnant Woman * Subjects whose has oral mucosal lichen planus. * Subjects whose oral mucosal findings is abnormal, but the diagnosis is unknown.

Design outcomes

Primary

MeasureTime frameDescription
DNA methylation labeled2 yearsTo validate the association between the methylation genes and the oral cancer

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026